HIMS
Hims Hers Health Inc
$23.47
+5.91%
Price vs EBITDA Yield
Current Valuation
- EBITDA Yield
- 1.85%
- EV/EBITDA
- 54.0x
- P/E Ratio
- 46.0x
- PEG Ratio
- 2.61
EV/EBITDA Averages
- Median (Fair Value)
- 71.0x
- Industry (Damodaran)
- 15.2x
- 1-Year Avg
- 45.3x
- 3-Year Avg
- 40.3x
- 5-Year Avg
- 39.8x
- Min / Max
- -159.0x / 377.9x
EBITDA Growth
- YoY Growth
- 11.7%
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- Current Margin
- 5.0%
Financial Snapshot
- Market Cap
- $5.35B
- Enterprise Value
- $5.89B
- Revenue (TTM)
- $2.35B
- Dividend Yield
- -
Valuation Context
vs 5-Year Average
36%
Above average (potentially overvalued)
EBITDA Yield
1.85%
Below average yield
vs Industry (Drugs (Pharmaceutica...)
254%
Above industry avg
Data Points
1253
daily data points